PsychoactiveMap

National Taiwan University Hospital psychedelic research trials

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

National Taiwan University Hospital is listed with 3 registered studies counted here, in Taipei, Taiwan. By compound: 3 ketamine. By registry status: 1 recruiting and 2 completed. By phase: 2 phase 3 and 1 phase 4. Reported start years run from 2020 (earliest) to 2026 (latest).

Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

By compound

Compound hubStudies
Ketamine3

By registry status

StatusStudiesShare
Recruiting133%
Completed267%

By phase

PhaseStudiesShare
Phase 3267%
Phase 4133%

Registered studies

All counted studies, newest start first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registeredRegistry IDStatusPhaseRegistry datesCompound
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454RecruitingPhase 3Source start: 2026-01-08 (actual)
Source date details

Start: 2026-01-08 (precision: day; source type: ACTUAL; actual)

Primary completion: 2031-04-09 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2031-09-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ketamine
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentNCT04829318CompletedPhase 4Source start: 2021-04-26 (actual)
Source date details

Start: 2021-04-26 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-07-22 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-07-22 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.827Z; registry revision: 2025-09-18 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ketamine
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive DisorderNCT04338321CompletedPhase 3Source start: 2020-08-21 (actual)
Source date details

Start: 2020-08-21 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-01-20 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-07-15 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:12.343Z; registry revision: 2025-04-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ketamine

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

Ketamine

Country hub: Taiwan

All trial hubs | Learn | Disclaimer